| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/19/2011 | EP2275430A1 Hemifumarate of a pyrazole derivative |
| 01/19/2011 | EP2275414A1 Cyclopentylacrylic acid amide derivative |
| 01/19/2011 | EP2275140A2 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities |
| 01/19/2011 | EP2275118A2 Pancreas-specific proteins |
| 01/19/2011 | EP2275117A1 GLP-1, exendin-4, peptide analogs and uses thereof |
| 01/19/2011 | EP2275109A2 Pregnane steroids for use in the treatment of CNS disorders |
| 01/19/2011 | EP2275108A1 Pharmaceutical preparation comprising dpp-iv inhibitor and other diabetes therapeutic agent in concomitant or combined form |
| 01/19/2011 | EP2275106A1 Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects |
| 01/19/2011 | EP2275102A1 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 01/19/2011 | EP2275091A1 Pharmaceutical compositions comprising adsorbates of an amorphous drug |
| 01/19/2011 | EP2274317A1 Synthesis of timosaponin bii |
| 01/19/2011 | EP2274315A1 Compositions comprising galactomannan and a process thereof |
| 01/19/2011 | EP2274308A1 Pyrrolotriazinone derivatives for use as stearoyl coa desaturase inhibitors |
| 01/19/2011 | EP2274299A1 Heteroaryl-substituted dicyanopyridines and use thereof for treatment of cardiovascular diseases |
| 01/19/2011 | EP2274297A1 Pyrrolidinone glucokinase activators |
| 01/19/2011 | EP2274053A2 Use of the human pancreatic polypeptide as a therapeutic agent |
| 01/19/2011 | EP2274000A2 Pharmaceutical or dietetic composition comprising an aqueous extract of nigella sativa |
| 01/19/2011 | EP2273994A2 Solid state forms of a pharmaceutical |
| 01/19/2011 | EP2273992A1 Quenolines and related analogs as sirtuin modulators |
| 01/19/2011 | EP1933818B1 Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels |
| 01/19/2011 | EP1879862B1 Magnesium salts of hmg-coa reductase inhibitors |
| 01/19/2011 | EP1804791B1 Tetrahydro pyridinyl pyrazole cannabinoid modulators |
| 01/19/2011 | EP1773867B1 Proteinaceous compounds and uses therefor |
| 01/19/2011 | EP1693456B1 Method of identifying modulators of a g protein-coupled receptor |
| 01/19/2011 | EP1600507B1 Mutant SREBP-1c promoters and use thereof |
| 01/19/2011 | EP1547614B1 Medicinal composition for inhibiting the expression of atp-citrate lyase and use thereof |
| 01/19/2011 | EP1481969B1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient |
| 01/19/2011 | EP1433776B1 Carba-sugar amine derivatives and treatments for disorder of glycolipid metabolism containing the same as the active ingredient |
| 01/19/2011 | EP1325019B1 Antisense modulation of clusterin expression |
| 01/19/2011 | EP1185296B1 Prevention and treatment of amyloidogenic diseases |
| 01/19/2011 | CN1977896B Composition with lipid-reducing function and its preparation and preparing method |
| 01/19/2011 | CN1950389B Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 01/19/2011 | CN101952293A Pyrazolo [1,5-A] pyrimidine compounds |
| 01/19/2011 | CN101952280A Bicyclic heterocyclic derivative |
| 01/19/2011 | CN101952276A 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases |
| 01/19/2011 | CN101952258A Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 01/19/2011 | CN101952257A Benzimidazole compounds |
| 01/19/2011 | CN101952243A 4-dimethylaminobutyric acid derivatives |
| 01/19/2011 | CN101951930A Oral or enteral composition useful for recovery of physical functions |
| 01/19/2011 | CN101951921A Method and means for the treatment of cachexia |
| 01/19/2011 | CN101951918A Treating hyperglycemia with 25-hydroxyvitamin D3 |
| 01/19/2011 | CN101951915A Oxsterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and WNT signaling |
| 01/19/2011 | CN101951904A Benzothiazole and benzoxazole derivatives and methods of use |
| 01/19/2011 | CN101948539A IL-18 binding proteins |
| 01/19/2011 | CN101948469A Method for synthesizing berberine citrate |
| 01/19/2011 | CN101948462A Azaspiroalkene and azaspiroalkane compounds with nicotinic cholinergic receptor activity |
| 01/19/2011 | CN101948425A Compound as glucocorticoid ligand, pharmaceutical composition including same, kit and method for preparing same |
| 01/19/2011 | CN101948416A Compound used for treating metabolic disorder |
| 01/19/2011 | CN101947306A Treatment of T-cell mediated diseases |
| 01/19/2011 | CN101947296A Chinese medicine composition for treating diabetes |
| 01/19/2011 | CN101947290A Medicament with yin-nourishing effect |
| 01/19/2011 | CN101947284A Traditional Chinese medicinal composition for treating diabetes and preparation method thereof |
| 01/19/2011 | CN101947281A Chinese medicament for treating diabetic peripheral neuritis |
| 01/19/2011 | CN101947275A Powder for treating diabetes mellitus and preparation method thereof |
| 01/19/2011 | CN101947251A Method for preparing chickpea isoflavone microcapsules |
| 01/19/2011 | CN101947244A Disinfection pill |
| 01/19/2011 | CN101947240A Mixed sugar electrolyte drug composite injection |
| 01/19/2011 | CN101947235A Medicamentous application of CPE (Conjugated Polyelectrolyte) |
| 01/19/2011 | CN101947232A Use of cactus pear fruit polysaccharides in preparation of medicaments or health-care products |
| 01/19/2011 | CN101947215A Application of flavonoid compound in tangerine peel to preparation of medicament for inhibiting angiogenesis |
| 01/19/2011 | CN101947214A Method for preparing vitamin A microcapsules by secondary emulsification and spray drying method |
| 01/19/2011 | CN101947206A Method for preparing recombinant pancreotropic hormone secretion peptide medicament microspheres |
| 01/19/2011 | CN101946985A Element fabric health-improving protective clothing capable of killing and repelling mosquitoes |
| 01/19/2011 | CN101560213B Polycyclic compound functioned as inhibitor of enzyme parp, vegfr2 and mlk3 and the application |
| 01/19/2011 | CN101485651B Dihydrochalcone derivates and use thereof |
| 01/19/2011 | CN101362731B Heterocyclic compounds and methods of use |
| 01/19/2011 | CN101297825B Compound formulation of ginkgo leaf extract |
| 01/19/2011 | CN101292685B Health care edible oil |
| 01/19/2011 | CN101287467B Methods and formulations for modulating Lyn kinase activity and treating related disorders |
| 01/19/2011 | CN101223956B Fast food instant porridge and preparing method thereof |
| 01/19/2011 | CN101209257B Medical use of baicalin and scutellarein derivatives |
| 01/19/2011 | CN101156947B Ginseng source peptide albumen, its preparing method and application |
| 01/19/2011 | CN101091695B Pharmaceutical formulation |
| 01/19/2011 | CN101019851B Medium chain fatty acid liposome and its preparation |
| 01/19/2011 | CN101014578B Triazole derivative or salt thereof |
| 01/18/2011 | US7872151 Inhibitors of α4 mediated cell adhesion |
| 01/18/2011 | US7872142 Coumarin derivatives useful as TNFα inhibitors |
| 01/18/2011 | US7872133 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma |
| 01/18/2011 | US7872129 Nitrogen compounds such as (6-(3-Methylaminopropyl)-2-(2-tri-fluoromethylphenyl)pyrimidin-4-yl)-(1H -pyrazolo(3,4-b)pyridin-3-yl)-amine, use as glycogen synthase kinase-3 (GSK-3) antagonists |
| 01/18/2011 | US7872125 1-Methyl,3-((1,3-dichloro-phenyl)-carbonylamino-(1-carboxy- eth-1,2-ylene)-(1,4-phenylene)-)quinazolin-2,4-dione; inhibiting the adhesion of VCAM-1 (vascular cellular adhesion molecules-1) to alpha-4 integrin; antiinflammatory agents; cardiovascular disorders; multiple sclerosis; antiarthritic agent |
| 01/18/2011 | US7872112 comprising rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A),deoxyhypusine synthase (DHS) nucleic acids and polypeptides; human cytomegalovirus immediate-early promoter/enhancer |
| 01/18/2011 | US7872098 derivatives of peptide corresponding to the sequence RIHMVYSKRSGKPRGYAFIEY pharmaceutical compositions; capable of stimulating in vitro the proliferation and the secretion of IL-2 by the CD4+ T cells purified from the ganglia |
| 01/18/2011 | US7872034 Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals |
| 01/18/2011 | US7871998 Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity |
| 01/18/2011 | US7871984 Suppress the immunoreactivity of a CpG motif and preventing and treating immune-mediated diseases such as arthritis |
| 01/18/2011 | US7871644 Mixture of drug, aminoacrylate polymer and acid |
| 01/18/2011 | US7871627 Gram positive bacteria preparations for the treatment of disease comprising an immune dysregulation |
| 01/18/2011 | CA2500225C Pyrazole compounds |
| 01/18/2011 | CA2475630C N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids |
| 01/18/2011 | CA2458797C Preparation and diabetic use of gibeberellins |
| 01/18/2011 | CA2432148C Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 01/18/2011 | CA2402893C .alpha.-amylase activity inhibitor |
| 01/18/2011 | CA2331460C Heterocyclic inhibitors of p38 |
| 01/18/2011 | CA2321881C Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications |
| 01/13/2011 | WO2011006070A2 Genetic association of polymorphisms in perilipin (plin) gene with resistance to weight loss |
| 01/13/2011 | WO2011006000A1 Berberine derivatives useful for modulating lipid levels and their methods of synthesis |
| 01/13/2011 | WO2011005929A1 Piperidine derivative and its use for the treatment of diabets and obesity |
| 01/13/2011 | WO2011005811A1 Combination therapy for the treatment of diabetes |
| 01/13/2011 | WO2011004734A1 Carboxymethylarginine production inhibitor and collagen denaturation inhibitor |
| 01/13/2011 | WO2011004733A1 Activity enhancer for oxidized protein hydrolase |